Thomas, M., Paranjape, M., & Sinclair, R. (2025). Rosacea fulminans following initiation of deucravacitinib. Clinical & Experimental Dermatology, 50(5), 1031. https://doi.org/10.1093/ced/llae495
Chicago Style (17th ed.) CitationThomas, Meryl, Meghana Paranjape, and Rodney Sinclair. "Rosacea Fulminans Following Initiation of Deucravacitinib." Clinical & Experimental Dermatology 50, no. 5 (2025): 1031. https://doi.org/10.1093/ced/llae495.
MLA (9th ed.) CitationThomas, Meryl, et al. "Rosacea Fulminans Following Initiation of Deucravacitinib." Clinical & Experimental Dermatology, vol. 50, no. 5, 2025, p. 1031, https://doi.org/10.1093/ced/llae495.
Warning: These citations may not always be 100% accurate.